In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease.

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia.

Not spending enough time in the two deep stages of sleep — slow-wave and rapid eye movement, or REM, sleep — may hasten the ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to ...

A new AI Alzheimer's detection tool can listen to voice recordings and accurately determine if you'll develop the disease.

Having already been hailed for their ability to aid weight loss and treat diabetes, GLP-1 drugs like Ozempic and Mounjaro ...

As the Trump administration makes major cuts to federal health agencies, including the National Institutes of Health, some Alzheimer’s experts are worried about research for the brain-impairing ...